Sort
50,496 grants matching “lung cancer”
Epidemiology of the four most frequent cancers following breast cancer
$932,958Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
$932,751Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2024 · CA
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
$932,751Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2023 · CA
Odorprint Based Disease Diagnostics
$932,693Dmitry Rinberg · New York University School Of Medicine · R01 · FY2025 · DC
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Lab
$932,550University Of California Los Angeles · N01 · FY2009 · CA
DNA Topoisomerases as Target of Action of Anticancer Drugs
$932,263Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment
$932,148David T Wong · University Of California Los Angeles · U01 · FY2023 · CA
Administrative Core
$932,129Trevor M. Penning · University Of Pennsylvania · P30 · FY2021 · ES
Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni
$932,044David E Kleiner · Clinical Sciences · Z01 · FY2007 · CA
Systems genetics analysis of tumor evolution in the mouse
$931,980Allan Balmain · University Of California, San Francisco · R35 · FY2022 · CA
Systems genetics analysis of tumor evolution in the mouse
$931,980Allan Balmain · University Of California, San Francisco · R35 · FY2023 · CA
Odorprint Based Disease Diagnostics
$931,815Dmitry Rinberg · New York University School Of Medicine · R01 · FY2023 · DC
TGF-betas in breast cancer progression
$931,521Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$931,198Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · CA
Stationary Anti-scatter Grids for Digital Breast Imaging
$931,101Cha-Mei Tang · Creatv Microtech, Inc. · R44 · FY2009 · CA
Role of the Epitranscriptome in Cancer
$931,087Richard I. Gregory · Boston Children'S Hospital · R35 · FY2019 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$931,042Xihong Lin · Harvard School Of Public Health · R35 · FY2021 · CA
IGF::OT::IGF CENTRAL DATA COLLECTION CENTER (CDCC)QUESTIONNAIRE AND BUCCAL CELL PROJECT. PERIOD OF PERFORMANCE: 09/19/2016 TO 09/18/2019
$930,760Sunitha Mathew · Westat, Inc. · N02 · FY2016 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$930,607Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
CLUE STUDIES--EVALUATING BIOMARKERS OF CARCINOGENESIS
$930,585Johns Hopkins University · U01 · FY2004 · CA
Optimizing Implementation in Cancer Control: OPTICC
$930,532Bryan J. Weiner · University Of Washington · P50 · FY2021 · CA
COP Laboratory
$930,529Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.
$930,483Glenn W Laub · Tdl Innovations, Llc · R44 · FY2019 · CA
Evaluating Whether a Concurrent Retinoid X Receptor Agonist can Enhance the Efficacy of the HER2-IGFPB2-IGF1R Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Inv
$930,464Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA
Gulf Longitudinal Follow-up (GuLF) Study
$930,455Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES